Breast cancer is the leading site of new cancer cases in women and is the second leading cause (after lung cancer) of cancer death among women. The high mortality rate associated with breast cancer, however, is due to a propensity for these tumors to spread while the primary tumors are small and undetected. The molecular mechanisms underlying the upstream regulation of the Wnt1 and STAT3, two major transforming molecules in human cancer and, in turn, progression and metastasis of these cancers are not completely understood at the present time, but believed to involve perturbation of master chromatin modifiers. For example, overexpression of metastatic tumor antigen 1 (MTA1), a master chromatin modifier, is frequently associated with an aggressive clinical course in human breast cancer. Despite the remarkable growth of information about MTA1, Wnt1, and STAT3, knowledge regarding the mechanism by which MTA1 and the direct targets of MTA1-containing coregulatory complexes regulate mammary epithelial cell transformation and metastasis remains elusive, and is the focus of this application. In this context, our recent work suggests that MTA1 deregulation in mammary epithelial cells plays a significant role in stimulating Wnt1 via targeting of specific gene chromatin, namely repressing Six3 (a direct corepressor of Wnt1), and STAT3 chromatin. In addition, for the first time, we discovered that MTA1 is required for breast-to-lung metastasis in a transgenic mouse model. This proposal is designed to establish the mechanism by which MTA1, a physiologic upstream regulator of Wnt1 and STAT3 gene chromatin, contributes to the development of neoplastic phenotypes in mammary epithelial cells and tumors. These findings offer a unique opportunity to study the first upstream common chromatin modifier of two pathways implicated in oncogenesis. Our working hypothesis is that "deregulation of MTA1 results in activation of the Wnt1, and STAT3 pathways, and consequently, confers neoplastic and metastatic properties to breast epithelial cells." To address these hypotheses, our Specific Aims are to: (1) Determine the mechanism of MTA1 regulation of Wnt1 expression, signaling, and functions in mammary epithelial cells;(2) Determine mechanism of MTA1-driven breast-to-lung metastasis;(3) Determine the expression characteristics and significance of MTA1 and its targets/effectors in human breast cancer. An innovative aspect of our proposal is the delineation of the mechanistic and functional significance of the MTA1- Wnt1, and the MTA1-STAT3 pathways in breast cancer cells. These studies will uniquely define the mechanisms of neoplastic and metastatic activities of MTA1. Our proposed research is significant, as the knowledge gained from this research will enhance our understanding of the critical regulatory pathways with established roles in breast cancer progression. In addition, this research will form the basis for new translational advances in identifying novel molecular targets, detecting, and treating breast cancer, by identifying MTA1 as a key master regulatory nodule.

Public Health Relevance

This proposal is based on the original findings that MTA1 is a physiologic modifier of the Wnt1 and STAT3, two gene products implicated in oncogenesis and metastasis. The proposal is designed to establish the mechanism by which MTA1 contributes to the development of tumorigenic phenotypes in mammary epithelial cells and tumors.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Research Project (R01)
Project #
Application #
Study Section
Tumor Cell Biology Study Section (TCB)
Program Officer
Snyderwine, Elizabeth G
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
George Washington University
Schools of Medicine
United States
Zip Code
Sen, Nirmalya; Gui, Bin; Kumar, Rakesh (2014) Physiological functions of MTA family of proteins. Cancer Metastasis Rev 33:869-77
Kumar, Rakesh (2014) Functions and clinical relevance of MTA proteins in human cancer. Preface. Cancer Metastasis Rev 33:835
Sen, Nirmalya; Gui, Bin; Kumar, Rakesh (2014) Role of MTA1 in cancer progression and metastasis. Cancer Metastasis Rev 33:879-89
Li, Da-Qiang; Pakala, Suresh B; Reddy, Sirigiri Divijendra Natha et al. (2013) Metastasis-associated protein 1 is an integral component of the circadian molecular machinery. Nat Commun 4:2545
Nair, Sujit S; Li, Da-Qiang; Kumar, Rakesh (2013) A core chromatin remodeling factor instructs global chromatin signaling through multivalent reading of nucleosome codes. Mol Cell 49:704-18
Pakala, Suresh B; Rayala, Suresh K; Wang, Rui-An et al. (2013) MTA1 promotes STAT3 transcription and pulmonary metastasis in breast cancer. Cancer Res 73:3761-70
Sankaran, Deivendran; Pakala, Suresh B; Nair, Vasudha S et al. (2012) Mechanism of MTA1 protein overexpression-linked invasion: MTA1 regulation of hyaluronan-mediated motility receptor (HMMR) expression and function. J Biol Chem 287:5483-91
Li, Da-Qiang; Pakala, Suresh B; Nair, Sujit S et al. (2012) Metastasis-associated protein 1/nucleosome remodeling and histone deacetylase complex in cancer. Cancer Res 72:387-94
Pakala, S B; Singh, K; Reddy, S D N et al. (2011) TGF-*1 signaling targets metastasis-associated protein 1, a new effector in epithelial cells. Oncogene 30:2230-41
Ghanta, Krishna Sumanth; Pakala, Suresh B; Reddy, Sirigiri Divijendra Natha et al. (2011) MTA1 coregulation of transglutaminase 2 expression and function during inflammatory response. J Biol Chem 286:7132-8

Showing the most recent 10 out of 76 publications